What is the normal range of endometrial thickness in premenopausal and postmenopausal women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Endometrial Thickness Range

In postmenopausal women, normal endometrial thickness is ≤4 mm, while in premenopausal women, normal thickness varies with menstrual cycle phase (approximately 3-13 mm) with no validated upper limit cutoff. 1

Postmenopausal Women

The evidence strongly supports a 4 mm threshold as the critical cutoff for postmenopausal women:

  • Endometrial thickness ≤4 mm conveys a negative predictive value for endometrial cancer of nearly 100% 1
  • Thickness ≥5 mm generally prompts endometrial tissue sampling due to concern for pathology 1
  • Mean thickness in asymptomatic postmenopausal women ranges from 1.4-2.3 mm 2, 3
  • The 3-4 mm cutoff range is supported by multiple guidelines, with some recommending ≤3 mm for optimal sensitivity 4

Important caveat: The 4 mm cutoff assumes complete endometrial visualization on transvaginal ultrasound. Incomplete visualization occurs more commonly with non-endometrioid cancers (34% vs 9.1%) and may lead to missed diagnoses, supporting universal endometrial sampling for postmenopausal bleeding regardless of thickness 5. Additionally, when endometrium is fully visualized, a 4 mm cutoff may still miss 5.6% of cancers 5.

Premenopausal Women

Normal endometrial thickness varies significantly with menstrual cycle phase 1:

  • Follicular phase: 3-13 mm (mean 7.8 mm) 2
  • Around ovulation: 8-13 mm (mean 10.4 mm) 2
  • Luteal phase: 8-19 mm (mean 10.4 mm) 2

Critical distinction: Unlike postmenopausal women, endometrial thickness in premenopausal women is NOT a reliable indicator of endometrial pathology 1. Even with thickness <5 mm, endometrial polyps or other pathology may be present 1. There is no validated absolute upper limit cutoff for premenopausal women 1.

Clinical Application Algorithm

For postmenopausal women with bleeding:

  1. Perform transvaginal ultrasound to measure endometrial thickness
  2. If ≤4 mm with complete visualization → NPV for cancer ~100%, but consider endometrial sampling per updated guidelines 1, 5
  3. If ≥5 mm OR incomplete visualization → proceed directly to endometrial tissue sampling 1

For premenopausal women:

  • Do not rely on thickness measurements alone for clinical decisions
  • Focus on abnormal echogenicity and texture rather than absolute thickness 1
  • Consider cycle phase when interpreting measurements

Common pitfall: Abnormal echogenicity and texture of the endometrium correlates with significant pathology in both pre- and postmenopausal women, independent of thickness measurements 1. Don't be falsely reassured by "normal" thickness if the endometrial appearance is heterogeneous or abnormal 6.

References

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Research

Measurement precision and normal range of endometrial thickness in a postmenopausal population by transvaginal ultrasound.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2002

Research

Measuring the thickness--is that all we have to do for sonographic assessment of endometrium in postmenopausal women?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.